Joshua R. Disbrow, Chief Executive Officer at AYTU BIOPHARMA, INC (AYTU), bought 15,000 shares at $1.30 ($20K) on 2025-02-28, disclosed to the SEC on 2025-03-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AYTU | BUY | 2023-06-15 | $26K | — | Filing → |
| AYTU | BUY | 2022-12-21 | $25K | — | Filing → |
| AYTU | BUY | 2022-11-28 | $53K | — | Filing → |